SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 21.25
+1.25 (6.25%)
Apr 17, 2025, 4:12 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 49.51 million as of April 17, 2025. Its market cap has increased by 170.30% in one year.
Market Cap
49.51M
Enterprise Value
49.30M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.25
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 49.51M, an increase of 214.75%. That is a compound annual growth rate of 15.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.57B |
| Haleon | 34.56B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.17B |
| HUTCHMED (China) | 1.77B |
| Oxford Nanopore Technologies | 1.12B |